.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Optimizing Outcomes in the Long-Term Management of Patients With AML

Catherine Lai, MD, MPH, discusses strategies for optimizing outcomes in the long-term management of Acute Myeloid Leukemia (AML), particularly for patients in first remission without a transplant. She also shares perspectives on updates from the 65th ASH Annual Meeting.

EP. 1: AML Update: Incidence, Risk Factors, and Prognosis

December 15th 2023

Join Catherine Lai, MD, MPH in this informative OncLive News Network program as she explores strategies for optimizing outcomes in the long-term management of Acute Myeloid Leukemia (AML), with a focus on patients in first remission without a transplant. Here, she provides a brief overview of the current incidence of AML, its risk factors, and prognosis.

Optimizing Outcomes in the Long-Term Management of Patients With AML

EP. 1: AML Update: Incidence, Risk Factors, and Prognosis

EP. 2: The Role of Molecular Testing in the Diagnosis of AML

EP. 3: First-Line Treatment Options for AML

EP. 4: Monitoring Patients Being Treated for AML

EP. 5: Treatment Options After Induction Chemotherapy Treatment

EP. 6: Maintenance Therapy for Patients With AML

EP. 7: The Goals of AML Maintenance Therapy

EP. 8: Continuity of Care During Maintenance Therapy

EP. 9: Challenges in Treating AML Upon First Remission

EP. 10: Looking Ahead: Unmet Needs in AML Management